CVE:NXG NexgenRx (NXG) Stock Price, News & Analysis → Bill Clinton Backing Biden Replacement??? (From The Freeport Society) (Ad) Free NXG Stock Alerts C$0.29 +0.01 (+1.75%) (As of 06/3/2024) Add Compare Share Share Today's RangeC$0.29▼C$0.2950-Day RangeC$0.20▼C$0.2952-Week RangeC$0.18▼C$0.32Volume2,500 shsAverage Volume34,040 shsMarket CapitalizationC$20.57 millionP/E RatioN/ADividend Yield3.45%Price TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades Get NexgenRx alerts: Email Address Ad Stansberry ResearchThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $0.35, AMZN under $2.50, and NVDA before it soared 1,200%. Recently, he sat down for an exclusive interview, revealing EXACTLY where to put your money this year. An investment vehicle he's so confident in, he says he'd put 50% of his kids' inheritance into this stock.You can get the name and ticker symbol, absolutely free, right here. About NexgenRxNexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.Read More NXG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NXG Stock News HeadlinesMay 28, 2024 | insidertrades.comNexgenRx Inc. (CVE:NXG) Director Ronald Campbell Loucks Purchases 120,000 SharesMay 17, 2024 | stockhouse.comNexgenRx Announces First Quarter Results, with 24% Revenue Growth and Record EarningsMay 16, 2024 | stockhouse.comNexgenRx Announces Annual Meeting ResultsMay 16, 2024 | theglobeandmail.comClosing Bell: Nexgenrx Inc down on Monday (NXG)May 11, 2024 | morningstar.comNexgenRx Inc NXGApril 30, 2024 | theglobeandmail.comNexgenRx: Top 10 Undervalued Healthcare Plans Industry Stocks (NXG)October 25, 2023 | seekingalpha.comNXG NXG NextGen Infrastructure Income FundAugust 26, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc flat on Friday (NXG)August 25, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc down on Thursday (NXG)August 22, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc up on Wednesday (NXG)June 16, 2023 | msn.comNexgenRx Inc. declares $0.005 dividendJune 15, 2023 | finanznachrichten.deNexgenRx Inc.: NexgenRx Announces Declaration of DividendMay 19, 2023 | msn.comNexgenRx reports Q1 resultsMay 10, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc down on Friday (NXG)May 8, 2023 | ca.finance.yahoo.comNexgenRx Inc. (NXG.V)May 6, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc up on Friday (NXG)May 4, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc down on Tuesday (NXG)April 21, 2023 | theglobeandmail.comClosing Bell: Nexgenrx Inc flat on Wednesday (NXG)March 6, 2023 | finance.yahoo.comIs NexgenRx Inc.'s (CVE:NXG) Recent Stock Performance Tethered To Its Strong Fundamentals?February 26, 2023 | nasdaq.comNXG NextGen Infrastructure Income Fund Common Shares of Beneficial Interest (NXG)February 20, 2023 | finance.yahoo.com733085 (NXG) Stock Historical Prices & Data - Yahoo FinanceSeptember 26, 2022 | finance.yahoo.comDeclining Stock and Solid Fundamentals: Is The Market Wrong About NexgenRx Inc. (CVE:NXG)?September 23, 2022 | finance.yahoo.comNexgenrx Announces Declaration Of DividendSeptember 12, 2022 | reuters.comNXG.V - NexgenRx Inc. | Stock Price & Latest News | ReutersDecember 21, 2021 | yahoo.comRETIRE ON TRACK: The real magic of investing begins when you start using ratiosSee More Headlines Receive NXG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NexgenRx and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/16/2024Today6/12/2024Next Earnings (Estimated)8/19/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeCVE SectorMedical Industry Healthcare Plans Sub-IndustryN/A Current SymbolCVE:NXG CUSIPN/A CIKN/A Webwww.nexgenrx.com Phone+1-416-6953393FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$3.06 million Net Margins-2.40% Pretax MarginN/A Return on Equity-4.01% Return on Assets-0.32% Debt Debt-to-Equity Ratio5.99 Current Ratio1.06 Quick Ratio0.12 Sales & Book Value Annual SalesC$13.85 million Price / Sales1.48 Cash FlowC$0.03 per share Price / Cash Flow9.64 Book ValueC$0.09 per share Price / Book3.22Miscellaneous Outstanding Shares70,920,000Free FloatN/AMarket CapC$20.57 million OptionableNot Optionable Beta0.25 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report Key ExecutivesMr. Ronald C. Loucks B.B.A. (Age 74)Founder, CEO, President & Director Comp: $313.34kMr. Kelly Elher C.A.CPA, CA, CPA, Chief Financial OfficerMr. Andrew MunroeSenior Vice President of Pharma & Payor PartnersMr. Jason RobinsonSenior Vice President of AdministrationMs. Doreen HarveyLead Human ResourcesMr. Paul Anthony Bolger LL.B.M.B.A., Company SecretaryMr. Avik DebroyFinancial ControllerMore ExecutivesKey CompetitorsTheratechnologiesTSE:THAssureCVE:IOMWeedMDCVE:WMDPediapharmCVE:PDPKDA GroupCVE:KDAView All CompetitorsInsidersRonald Campbell LoucksBought 120,000 shares on 5/24/2024Total: C$33,600.00 ($0.28/share)View All Insider Transactions NXG Stock Analysis - Frequently Asked Questions How have NXG shares performed in 2024? NexgenRx's stock was trading at C$0.22 at the start of the year. Since then, NXG shares have increased by 31.8% and is now trading at C$0.29. View the best growth stocks for 2024 here. When is NexgenRx's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 19th 2024. View our NXG earnings forecast. How were NexgenRx's earnings last quarter? NexgenRx Inc. (CVE:NXG) announced its quarterly earnings data on Thursday, May, 16th. The company reported $0.01 earnings per share for the quarter. The company earned $4.29 million during the quarter. NexgenRx had a negative trailing twelve-month return on equity of 4.01% and a negative net margin of 2.40%. Is NexgenRx a good dividend stock? NexgenRx (CVE:NXG) pays an annual dividend of C$0.01 per share and currently has a dividend yield of 4.17%. NXG has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. What other stocks do shareholders of NexgenRx own? Based on aggregate information from My MarketBeat watchlists, some companies that other NexgenRx investors own include WestJet Airlines (WJA) and Hydro One (H). How do I buy shares of NexgenRx? Shares of NXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. This page (CVE:NXG) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!The FEDNOW Biden Dollar ends cash in a matter of WEEKS Stumbling Biden's dollar next phases begins Oct 21st...American Alternative | Sponsored$9 AI Model with 90% Win Rate?What if I told you it could take just $9… To win 90% of your options trades?Trade Machine | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NexgenRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NexgenRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.